CPIX Cumberland Pharmaceuticals Inc

Price (delayed)

$7.9

Market cap

$118.37M

P/E Ratio

N/A

Dividend/share

$1.5

EPS

-$0.73

Enterprise value

$119.22M

?
Relative Growth: Rel. Growth: 4
Relative Strength: Rel. Strength: 98
Relative Valuation: Rel. Valuation: 15
Relative Profitability: Rel. Profitability: 22

Cumberland Pharmaceuticals Inc. is the largest biopharmaceutical company founded and headquartered in Tennessee and is focused on developing innovative products that improve the quality of patient care. The company is ...

Highlights
The company's debt has shrunk by 68% QoQ and by 54% YoY
The quick ratio has shrunk by 55% YoY and by 33% QoQ
Cumberland Pharmaceuticals's EPS has decreased by 49% from the previous quarter

Key stats

What are the main financial stats of CPIX

CPIX stock price

How has the Cumberland Pharmaceuticals stock price performed over time
Intraday
-0.13%
1 week
2.86%
1 month
20.8%
1 year
169.62%
YTD
98.49%
QTD
21.91%

Financial performance

How have Cumberland Pharmaceuticals's revenue and profit performed over time
Revenue
$31.27M
Gross profit
$26.1M
Operating income
-$9.63M
Net income
-$10.92M
Gross margin
83.5%
Net margin
-34.9%
The company's operating margin has shrunk by 81% YoY
CPIX's operating income has dropped by 79% year-on-year
The company's net margin fell by 49% QoQ
The net income fell by 48% QoQ

Price vs fundamentals

How does CPIX's price correlate with its fundamentals

Growth

What is Cumberland Pharmaceuticals's growth rate over time

Valuation

What is Cumberland Pharmaceuticals stock price valuation
P/E
N/A
P/B
6.79
P/S
3.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.81
Cumberland Pharmaceuticals's EPS has decreased by 49% from the previous quarter
CPIX's P/B is 126% above its last 4 quarters average of 3.0
CPIX's equity is down by 38% year-on-year and by 19% since the previous quarter
The stock's price to sales (P/S) is 99% more than its last 4 quarters average of 1.9

Efficiency

How efficient is Cumberland Pharmaceuticals business performance
The company's return on equity has shrunk by 66% QoQ
Cumberland Pharmaceuticals's ROS has plunged by 52% from the previous quarter
The ROA has plunged by 50% from the previous quarter
CPIX's return on invested capital is down by 41% since the previous quarter

Dividends

What is CPIX's dividend history
DPS
$1.5
Dividend yield
18.99%
Payout ratio
N/A
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Cumberland Pharmaceuticals financials performed over time
The total assets is 37% greater than the total liabilities
The quick ratio has shrunk by 55% YoY and by 33% QoQ
The current ratio is down by 26% year-on-year
The company's debt is 73% lower than its equity
The company's debt has shrunk by 68% QoQ and by 54% YoY
The debt to equity has plunged by 60% from the previous quarter and by 27% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.